These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 16229909

  • 1. Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.
    Guech-Ongey M, Brenner H, Twardella D, Hahmann H, Rothenbacher D.
    Int J Cardiol; 2006 Jul 28; 111(1):98-103. PubMed ID: 16229909
    [Abstract] [Full Text] [Related]

  • 2. Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study.
    Guech-Ongey M, Brenner H, Twardella D, Rothenbacher D.
    BMC Cardiovasc Disord; 2006 Apr 12; 6():17. PubMed ID: 16608530
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.
    Rothenbacher D, Brenner H, Mertens T, Hoffmann MM, Hoffmeister A, Koenig W.
    BMC Cardiovasc Disord; 2005 May 20; 5(1):10. PubMed ID: 15943888
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM, Visseren FL, Algra A, van der Graaf Y, SMART Study Group.
    Diabet Med; 2007 Dec 20; 24(12):1352-60. PubMed ID: 18042079
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E, Lanio N, Gallego A, Rodriguez-Molina J, Navarro J, Fernandez-Yañez J, Palomo J, Rodríguez-Hernández C, Ruiz M, Alonso R, Fernandez-Cruz E, Carbone J.
    Int Immunopharmacol; 2009 Jun 20; 9(6):649-52. PubMed ID: 18940269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS, Pencina MJ, D'Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS.
    J Am Coll Cardiol; 2008 Jan 22; 51(3):264-70. PubMed ID: 18206734
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS).
    Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR, Greenland P, Ridker PM, Glynn RJ.
    Circulation; 2004 Apr 06; 109(13):1623-9. PubMed ID: 15023883
    [Abstract] [Full Text] [Related]

  • 12. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA, Glynn RJ, Buring J, Ridker PM.
    Circulation; 2006 Dec 12; 114(24):2619-26. PubMed ID: 17116764
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-cytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis.
    Blum A, Peleg A, Weinberg M.
    Clin Exp Med; 2003 Nov 12; 3(3):157-60. PubMed ID: 14648230
    [Abstract] [Full Text] [Related]

  • 15. Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study.
    Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas I, Stefanadis C, ATTICA Study.
    Vasc Med; 2008 Nov 12; 13(2):113-21. PubMed ID: 18593800
    [Abstract] [Full Text] [Related]

  • 16. IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes.
    Wallander M, Norhammar A, Malmberg K, Ohrvik J, Rydén L, Brismar K.
    Diabetes Care; 2007 Sep 12; 30(9):2343-8. PubMed ID: 17563335
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry.
    Hackam DG, Tan MK, Honos GN, Leiter LA, Langer A, Goodman SG, Vascular Protection registry investigators.
    Am Heart J; 2004 Dec 12; 148(6):1028-33. PubMed ID: 15632889
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C, German Diabetes and Dialysis Study Investigators.
    Am J Kidney Dis; 2009 Nov 12; 54(5):902-11. PubMed ID: 19781835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.